MONEY Eli Lilly, Regeneron named to FDA pilot program to boost US drug manufacturing Jun 29, 2026 Finance Desk Thibault Renard/iStock via Getty Images Eli Lilly (LLY) and Regeneron Pharmaceuticals (REGN) are among seven drug companies selected by the US FDA to become a part of the FDA PreCheck Pilot Program, which is designed to improve US drug manufacturing capabilities. The program provides “earlier FDA Source link
